Teleflex Incorporated reported $2.25B of revenue over the trailing twelve months, +31% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $2.25B (to Q2 2026). Net income: −$1.03B, trailing twelve months to Q2 2026. Free cash flow: $168M, trailing twelve months to Q2 2026. Operating margin: 2.0%, trailing twelve months to Q2 2026.

TFXTeleflex Incorporated

Healthcare

$125.11+2.9% 1Y

$125.11

$99.7952 weeks$142.09

TFX as reported

Teleflex Incorporated reported $2.25B of revenue over the trailing twelve months, +31% on the year before. 11 reported series are charted on this page, each one as filed.

$2.25B

Revenue, trailing twelve months · to Q2 2026 · +31% against the twelve months before

Net income: −$1.03B
Net income · −638% year on year · trailing twelve months to Q2 2026
Free cash flow: $168M
Free cash flow · +1434% year on year · trailing twelve months to Q2 2026
Operating margin: 2.0%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for TFX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$2.25B	+31%	Q2 2026
Net income	−$1.03B	−638%	Q2 2026
EPS	−$23.29	−645%	Q2 2026
Gross margin	55%	n/a	Q2 2026
Operating margin	2.0%	n/a	Q2 2026
Net margin	−45%	n/a	Q2 2026
ROE	−26%	n/a	Q2 2026
ROA	−12%	n/a	Q2 2026
ROIC	1.3%	n/a	Q2 2026
Free cash flow	$168M	+1434%	Q2 2026
P/E	60.0	n/a	Q2 2025 · 4 quarters behind

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.